- In October 2023, a study published in the BMJ Journal of Neurointerventional Surgery revealed that PreSize, an AI software, outperformed human clinicians in predicting the placement of stents in patients' brains. This advancement highlights the potential of AI integration to create growth opportunities for companies in the neurointerventional market
- In July 2023, MicroVention, Inc., a subsidiary of Terumo Corporation, released the WEB-IT five-year follow-up data and introduced two new sizes to its WEB Aneurysm Embolization System. With seven Good Clinical Practice (GCP) studies and over 200 peer-reviewed publications, the WEB system is now the most extensively studied intrasaccular device available
- In May 2023, Stryker Corporation completed the acquisition of Cerus Endovascular Ltd., a medical device company specializing in neurointerventional products for intracranial aneurysms. This acquisition aims to enhance Stryker’s product portfolio for aneurysm treatment solutions
- In June 2022, the Indian subsidiary of Medtronic plc launched the Pipeline Vantage Embolization Device in India, a cutting-edge solution for the treatment of brain aneurysms
- In October 2021, Evasc Neurovascular introduced the third generation of its eCLIPs Bifurcation Flow Diverter, featuring a shapeable delivery wire, smaller size compatible with 0.021” and 0.027” ID microcatheters, and electrolytic detachment, making it more effective for treating intracranial bifurcation aneurysms
Frequently Asked Questions
The market is segmented based on Segmentation, By Type (Aortic Aneurysm, Cerebral Aneurysm, and Others), Shape (Fusiform Aneurysms Bulge, Saccular Aneurysms Bulge, and Others), Treatment Type (Medication, Surgery, and Others), Route of Administration (Oral, Injectable, and Others), End-Users (Hospitals, Homecare, Specialty Clinics, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others) – Industry Trends and Forecast to 2032
.
The Global Aneurysm Treatment Market size was valued at USD 5.97 USD Billion in 2024.
The Global Aneurysm Treatment Market is projected to grow at a CAGR of 7.24% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
